{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:06:14Z","timestamp":1790784374553,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"5","funder":[{"name":"NIH","award":["CA109545"],"award-info":[{"award-number":["CA109545"]}]},{"name":"NIH","award":["CA194697"],"award-info":[{"award-number":["CA194697"]}]},{"name":"NIH","award":["KO1CA218305"],"award-info":[{"award-number":["KO1CA218305"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The noncanonical Wnt ligand Wnt5a is found in high concentrations in ascites of women with ovarian cancer. In this study, we elucidated the role of Wnt5a in ovarian cancer metastasis. Wnt5a promoted ovarian tumor cell adhesion to peritoneal mesothelial cells as well as migration and invasion, leading to colonization of peritoneal explants. Host components of the ovarian tumor microenvironment, notably peritoneal mesothelial cells and visceral adipose, secreted Wnt5a. Conditional knockout of host WNT5A significantly reduced peritoneal metastatic tumor burden. Tumors formed in WNT5A knockout mice had elevated cytotoxic T cells, increased M1 macrophages, and decreased M2 macrophages, indicating that host Wnt5a promotes an immunosuppressive microenvironment. The Src family kinase Fgr was identified as a downstream effector of Wnt5a. These results highlight a previously unreported role for host-expressed Wnt5a in ovarian cancer metastasis and suggest Fgr as a novel target for inhibition of ovarian cancer metastatic progression.<\/jats:p>\n                  <jats:p>Significance: This study establishes host-derived Wnt5a, expressed by peritoneal mesothelial cells and adipocytes, as a primary regulator of ovarian cancer intraperitoneal metastatic dissemination and identifies Fgr kinase as novel target for inhibition of metastasis.<\/jats:p>","DOI":"10.1158\/0008-5472.can-19-1601","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T17:15:52Z","timestamp":1578935752000},"page":"1156-1170","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis"],"prefix":"10.1158","volume":"80","author":[{"given":"Marwa","family":"Asem","sequence":"first","affiliation":[{"name":"1Integrated Biomedical Sciences Program, University of Notre Dame, South Bend, Indiana."},{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Young","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-2139","authenticated-orcid":false,"given":"Carlysa","family":"Oyama","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1823-4940","authenticated-orcid":false,"given":"Alejandro","family":"Claure De La Zerda","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Liu","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyvette S.","family":"Hilliard","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Johnson","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth I.","family":"Harper","sequence":"additional","affiliation":[{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Guldner","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."},{"name":"4Department of Biological Sciences, University of Notre Dame; South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0910-3666","authenticated-orcid":false,"given":"Siyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."},{"name":"4Department of Biological Sciences, University of Notre Dame; South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Page-Mayberry","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-1633","authenticated-orcid":false,"given":"William J.","family":"Kaliney","sequence":"additional","affiliation":[{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sharon","family":"Stack","sequence":"additional","affiliation":[{"name":"1Integrated Biomedical Sciences Program, University of Notre Dame, South Bend, Indiana."},{"name":"2Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, Indiana."},{"name":"3Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"2022061706274762800_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022061706274762800_bib2","doi-asserted-by":"crossref","first-page":"e24709","DOI":"10.1371\/journal.pone.0024709","article-title":"Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles","volume":"6","author":"Mankoo","year":"2011","journal-title":"PLoS One"},{"key":"2022061706274762800_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1101\/gr.161026.113","article-title":"Genomic and transcriptomic plasticity in treatment-naive ovarian cancer","volume":"24","author":"Hoogstraat","year":"2014","journal-title":"Genome Res"},{"key":"2022061706274762800_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/path.4042","article-title":"Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes","volume":"227","author":"McBride","year":"2012","journal-title":"J Pathol"},{"key":"2022061706274762800_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","article-title":"New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination","volume":"175","author":"Coffman","year":"2016","journal-title":"Transl Res"},{"key":"2022061706274762800_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"2022061706274762800_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front Oncol"},{"key":"2022061706274762800_bib8","doi-asserted-by":"crossref","unstructured":"Asem\u2008MS\n          .\u2008Wnt5a signaling in cancer.\u20082016;8:79.","DOI":"10.3390\/cancers8090079"},{"key":"2022061706274762800_bib9","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1158\/0008-5472.CAN-11-1341","article-title":"Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence","volume":"71","author":"Bitler","year":"2011","journal-title":"Cancer Res"},{"key":"2022061706274762800_bib10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","article-title":"Alternative Wnt signaling activates YAP\/TAZ","volume":"162","author":"Park","year":"2015","journal-title":"Cell"},{"key":"2022061706274762800_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ygyno.2014.06.004","article-title":"The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer","volume":"134","author":"Ford","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2022061706274762800_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.tranon.2018.07.010","article-title":"Expression analysis of platinum sensitive and resistant epithelial ovarian cancer patient samples reveals new candidates for targeted therapies","volume":"11","author":"Veskim\u00e4e","year":"2018","journal-title":"Transl Oncol"},{"key":"2022061706274762800_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"2022061706274762800_bib14","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1158\/0008-5472.CAN-15-0706","article-title":"Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res"},{"key":"2022061706274762800_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11626-015-9885-z","article-title":"Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line","volume":"51","author":"Blum","year":"2015","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2022061706274762800_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-0-387-98094-2_16","article-title":"Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis","volume":"149","author":"Kenny","year":"2009","journal-title":"Cancer Treat Res"},{"key":"2022061706274762800_bib17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/db14-1164","article-title":"Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion","volume":"64","author":"Fuster","year":"2015","journal-title":"Diabetes"},{"key":"2022061706274762800_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neo.2018.03.007","article-title":"Aging Increases susceptibility to ovarian cancer metastasis in murine allograft models and alters immune composition of peritoneal adipose tissue","volume":"20","author":"Loughran","year":"2018","journal-title":"Neoplasia"},{"key":"2022061706274762800_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-012-9351-2","article-title":"Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis","volume":"31","author":"Sodek","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"2022061706274762800_bib20","first-page":"S2","article-title":"Peritoneal membrane morphology and function","volume":"56","author":"Nagy","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"2022061706274762800_bib21","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2013.321","article-title":"Epithelial ovarian cancer experimental models","volume":"33","author":"Lengyel","year":"2014","journal-title":"Oncogene"},{"key":"2022061706274762800_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110112","article-title":"Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment","volume":"437","author":"Barbolina","year":"2011","journal-title":"Biochem J"},{"key":"2022061706274762800_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2022061706274762800_bib24","doi-asserted-by":"crossref","first-page":"E1407","DOI":"10.1210\/jc.2014-1191","article-title":"Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation","volume":"99","author":"Catal\u00e1n","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2022061706274762800_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/1471-2407-12-480","article-title":"Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression","volume":"12","author":"Jin","year":"2012","journal-title":"BMC Cancer"},{"key":"2022061706274762800_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jbmr.1488","article-title":"WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production","volume":"27","author":"Rauner","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2022061706274762800_bib27","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2008-08-175869","article-title":"Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration","volume":"114","author":"Ghosh","year":"2009","journal-title":"Blood"},{"key":"2022061706274762800_bib28","doi-asserted-by":"crossref","first-page":"e85058","DOI":"10.1371\/journal.pone.0085058","article-title":"GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"2022061706274762800_bib29","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.4049\/jimmunol.0904084","article-title":"Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses","volume":"184","author":"Hoelzinger","year":"2010","journal-title":"J Immunol"},{"key":"2022061706274762800_bib30","doi-asserted-by":"crossref","first-page":"e71207","DOI":"10.1371\/journal.pone.0071207","article-title":"Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion","volume":"8","author":"Marazioti","year":"2013","journal-title":"PLoS One"},{"key":"2022061706274762800_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ol.2011.300","article-title":"The emerging role of CXCL10 in cancer (Review)","volume":"2","author":"Liu","year":"2011","journal-title":"Oncol Lett"},{"key":"2022061706274762800_bib32","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-gamma in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022061706274762800_bib33","doi-asserted-by":"crossref","first-page":"e80063","DOI":"10.1371\/journal.pone.0080063","article-title":"The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer","volume":"8","author":"Preston","year":"2013","journal-title":"PLoS One"},{"key":"2022061706274762800_bib34","doi-asserted-by":"crossref","first-page":"E366","DOI":"10.3390\/cancers10100366","article-title":"Bipolar tumor-associated macrophages in ovarian cancer as targets for therapy","volume":"10","author":"Gupta","year":"2018","journal-title":"Cancers"},{"key":"2022061706274762800_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-2215-7-19","article-title":"A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients","volume":"7","author":"Zhang","year":"2014","journal-title":"J Ovarian Rese"},{"key":"2022061706274762800_bib36","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/jcp.25687","article-title":"Role of Wnt5a in the pathogenesis of inflammatory diseases","volume":"232","author":"Pashirzad","year":"2017","journal-title":"J Cell Physiol"},{"key":"2022061706274762800_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcancer.2005.07.006","article-title":"Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators","volume":"16","author":"Ben-Baruch","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"2022061706274762800_bib38","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ijc.24378","article-title":"Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression","volume":"125","author":"Fujimoto","year":"2009","journal-title":"Int J Cancer"},{"key":"2022061706274762800_bib39","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1186\/s12885-018-5117-8","article-title":"CCL1 is a major regulatory T cell attracting factor in human breast cancer","volume":"18","author":"Kuehnemuth","year":"2018","journal-title":"BMC Cancer"},{"key":"2022061706274762800_bib40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/imt-2018-0158","article-title":"Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-alpha and IFN-gamma mediate antitumor effects in vitro and in a mouse model of human ovarian cancer","volume":"11","author":"Green","year":"2019","journal-title":"Immunotherapy"},{"key":"2022061706274762800_bib41","first-page":"2487","article-title":"IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro","volume":"9","author":"Wall","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2022061706274762800_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cytogfr.2016.02.006","article-title":"Monocyte and interferon based therapy for the treatment of ovarian cancer","volume":"29","author":"Green","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022061706274762800_bib43","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.3390\/ijms19010089","article-title":"The dark side of IFN-gamma: its role in promoting cancer immunoevasion","volume":"19","author":"Mojic","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2022061706274762800_bib44","doi-asserted-by":"crossref","first-page":"865819","DOI":"10.1155\/2011\/865819","article-title":"Regulation of SRC family kinases in human cancers","volume":"2011","author":"Sen","year":"2011","journal-title":"J Signal Transduct"},{"key":"2022061706274762800_bib45","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1078-0432.CCR-12-2243","article-title":"New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential","volume":"19","author":"Banerjee","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2022061706274762800_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2012.06.009","article-title":"Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study","volume":"127","author":"Schilder","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2022061706274762800_bib47","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/annonc\/mdu363","article-title":"A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancerdagger","volume":"25","author":"McNeish","year":"2014","journal-title":"Ann Oncol"},{"key":"2022061706274762800_bib48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-10-2081","article-title":"Functional roles of Src and Fgr in ovarian carcinoma","volume":"17","author":"Kim","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022061706274762800_bib49","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1084\/jem.20132496","article-title":"The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment","volume":"211","author":"Kov\u00e1cs","year":"2014","journal-title":"J Exp Med"},{"key":"2022061706274762800_bib50","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4049\/jimmunol.1402011","article-title":"The Src-family kinases Hck and Fgr regulate early lipopolysaccharide-induced myeloid cell recruitment into the lung and their ability to secrete chemokines","volume":"195","author":"Mazzi","year":"2015","journal-title":"J Immunol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/80\/5\/1156\/2802175\/1156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/80\/5\/1156\/2802175\/1156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T14:40:13Z","timestamp":1655476813000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/80\/5\/1156\/647755\/Host-Wnt5a-Potentiates-Microenvironmental"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3,2]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-19-1601","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22424355.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22424355","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6511755","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6511755.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}